HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level

[1] O'Leary JG(2015)Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 15 1003-1013

[2] Kaneku H(2011)High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 11 1868-1876

[3] Banuelos N(2012)Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation Liver Int 32 1253-1261

[4] Jennings LW(2014)Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches Curr Opin Organ Transplant 19 591-597

[5] Klintmalm GB(2014)Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 14 867-875

[6] Terasaki PI(2016)Diagnostics and treatment of a severe humoral rejection after liver transplantation: donor-specific antibodies as a still underestimated cause of graft failure Z Gastroenterol 54 647-652

[7] O'Leary JG(2016)Donor-specific antibodies and liver transplantation Hum Immunol 77 1063-1070

[8] Kaneku H(2016)Impact of donor-specific antibodies on graft fibrosis after pediatric living donor liver transplantation for biliary atresia Transplant Proc 48 1095-1099

[9] Susskind BM(2016)Donor-specific antibodies require preactivated immune system to harm renal transplant EBioMedicine. 9 366-371

[10] Jennings LW(2018)Is there a need for additional DQ matching? Clin J Am Soc Nephrol 13 683-684

[1] O'Leary JG(2015)Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 15 1003-1013

[2] Kaneku H(2011)High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 11 1868-1876

[3] Banuelos N(2012)Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation Liver Int 32 1253-1261

[4] Jennings LW(2014)Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches Curr Opin Organ Transplant 19 591-597

[5] Klintmalm GB(2014)Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 14 867-875

[6] Terasaki PI(2016)Diagnostics and treatment of a severe humoral rejection after liver transplantation: donor-specific antibodies as a still underestimated cause of graft failure Z Gastroenterol 54 647-652

[7] O'Leary JG(2016)Donor-specific antibodies and liver transplantation Hum Immunol 77 1063-1070

[8] Kaneku H(2016)Impact of donor-specific antibodies on graft fibrosis after pediatric living donor liver transplantation for biliary atresia Transplant Proc 48 1095-1099

[9] Susskind BM(2016)Donor-specific antibodies require preactivated immune system to harm renal transplant EBioMedicine. 9 366-371

[10] Jennings LW(2018)Is there a need for additional DQ matching? Clin J Am Soc Nephrol 13 683-684